[A case of postoperative recurrent lung cancer with long survival due to gefitinib efficacy].
A 70-year-old woman underwent a right middle lobectomy and partial resection of right upper lobe for lung cancer. The pathological findings were well-differentiated adenocarcinoma, pT2N0M0, Stage IB. About 6 years after the operation, the serum CEA level increased and chest CT revealed right pleural dissemination and right pleural effusion. We diagnosed it as a recurrence of the lung cancer. Although we recommended chemotherapy, she hesitated and went without treatment for about 1 year. Then, 1 month after beginning gefitinib, her serum CEA level normalized and the recurrent lesion disappeared on chest CT. She has since a shown complete response with gefitinib for over 4 years and is still alive.